Stephanie J. Schrag

Q: What Schools Are Affiliated With Stephanie J. Schrag

Stephanie J. Schrag is affiliated with the following schools: Emory University, Indiana University, University of Oxford

Stephanie J. Schrag's AcademicInfluence.com Rankings

Stephanie J. Schrag

Medical

#2365

World Rank

#2786

Historical Rank

Epidemiology

#419

World Rank

#439

Historical Rank

medical Degrees

Stephanie J. Schrag

Philosophy

#6881

World Rank

#9993

Historical Rank

Logic

#3973

World Rank

#5211

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Stephanie J. Schrag's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Stephanie J. Schrag Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephanie J. Schrag's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (2010) (2722)
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. (2010) (993)
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. (2000) (989)
Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues (2011) (897)
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. (2008) (687)
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. (2002) (574)
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis (2012) (516)
US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. (2015) (469)
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. (2022) (411)
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. (2009) (402)
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli (1997) (387)
PREVENTION OF PERINATAL GROUP B STREPTOCOCCAL DISEASE (2002) (339)
The population genetics of antibiotic resistance. (1997) (338)
Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014 (2016) (301)
The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008 (2011) (297)
Evaluation of universal antenatal screening for group B streptococcus. (2009) (295)
Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children (2017) (279)
Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses (2017) (273)
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 (2022) (267)
Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. (2001) (257)
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings (2021) (252)
Emerging infectious disease: what are the relative roles of ecology and evolution? (1995) (249)
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 (2022) (244)
Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. (2013) (242)
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study (2022) (242)
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses (2017) (241)
Reducing antibiotic resistance (1996) (240)
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021 (2021) (232)
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. (2003) (224)
Applying Network Theory to Epidemics: Control Measures for Mycoplasma pneumoniae Outbreaks (2003) (214)
Application of TaqMan Low-Density Arrays for Simultaneous Detection of Multiple Respiratory Pathogens (2011) (207)
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. (2004) (186)
Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to β-Lactam Antibiotics (2008) (185)
Perinatal infections due to group B streptococci. (2004) (184)
Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance (2019) (180)
Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis (2008) (179)
Host-Parasite Coexistence: The Role of Spatial Refuges in Stabilizing Bacteria-Phage Interactions (1996) (169)
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 (2021) (160)
Trends in perinatal group B streptococcal disease - United States, 2000-2006. (2009) (152)
Vital Signs: Deficiencies in Environmental Control Identified in Outbreaks of Legionnaires' Disease - North America, 2000-2014. (2016) (150)
Morbidity and Mortality Weekly Report (MMWR) Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010 Recommendations and Reports (2010) (149)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 (2021) (148)
Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 (2006) (145)
Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. (2016) (143)
Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections (2016) (141)
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel (2021) (139)
Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use (2006) (136)
Group B streptococcal disease in infants: progress in prevention and continued challenges. (2010) (135)
Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates (2009) (133)
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. (2013) (126)
Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. (2020) (125)
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses (2017) (124)
Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. (2010) (123)
Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study (2018) (122)
Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review (2017) (122)
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021 (2021) (122)
Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. (2011) (122)
Prenatal screening for infectious diseases and opportunities for prevention. (2003) (119)
Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses (2017) (117)
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 (2021) (109)
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016 (2019) (108)
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (2021) (108)
Vaccination and Perinatal Infection Prevention Practices Among Obstetrician–Gynecologists (2003) (107)
Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. (2008) (105)
Spontaneous Mutation Rate of Measles Virus: Direct Estimation Based on Mutations Conferring Monoclonal Antibody Resistance (1999) (104)
Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses (2017) (104)
A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates (2003) (103)
Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn Dyads (2011) (103)
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States (2021) (101)
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021 (2021) (100)
Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia (2018) (100)
Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. (2000) (98)
Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin (2004) (98)
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 (2022) (97)
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial (2009) (97)
Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses (2017) (93)
Methicillin-Resistant and Susceptible Staphylococcus aureus Bacteremia and Meningitis in Preterm Infants (2012) (93)
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya (2016) (88)
Effectiveness of Intrapartum Antibiotic Prophylaxis for Prevention of Early-Onset Group B Streptococcal Disease (2013) (84)
Estimating Influenza Hospitalizations among Children (2006) (82)
Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses (2017) (82)
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016 (2016) (81)
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization (2021) (79)
Increased Risk for Group B Streptococcus Sepsis in Young Infants Exposed to HIV, Soweto, South Africa, 2004–2008 (2015) (76)
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries (2016) (67)
Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? (2017) (66)
Implementing an Ebola Vaccine Study - Sierra Leone. (2016) (64)
The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV[INCREMENT]G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak (2018) (64)
Risk Factors for Neonatal Sepsis and Perinatal Death Among Infants Enrolled in the Prevention of Perinatal Sepsis Trial, Soweto, South Africa (2012) (64)
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 (2021) (63)
Optimization of Multiple Pathogen Detection Using the TaqMan Array Card: Application for a Population-Based Study of Neonatal Infection (2013) (61)
Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study (2008) (59)
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States (2021) (59)
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance. (2022) (59)
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. (2014) (58)
Ecological Correlates of Male Outcrossing Ability in a Simultaneous Hermaphrodite Snail (1994) (58)
Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. (2006) (57)
Kawasaki Disease and Human Coronavirus (2005) (56)
Clinical sepsis in neonates and young infants, United States, 1988-2006. (2012) (55)
Early-Onset Group B Streptococcal Disease in the United States: Potential for Further Reduction (2014) (55)
Maternal HIV Infection and Vertical Transmission of Pathogenic Bacteria (2012) (53)
Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis (2017) (51)
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society (2005) (49)
Twenty Years of Active Bacterial Core Surveillance (2015) (47)
Vital Signs: Health Care–Associated Legionnaires’ Disease Surveillance Data From 20 States and a Large Metropolitan Area—United States, 2015 (2017) (47)
vanG Element Insertions within a Conserved Chromosomal Site Conferring Vancomycin Resistance to Streptococcus agalactiae and Streptococcus anginosus (2014) (46)
Adherence to Perinatal Group B Streptococcal Prevention Guidelines (2010) (46)
Effectiveness of Six Improved Cookstoves in Reducing Household Air Pollution and Their Acceptability in Rural Western Kenya (2016) (45)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 (2022) (45)
Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study (2021) (43)
Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit. (2010) (43)
Resistant pneumococcal infections: the burden of disease and challenges in monitoring and controlling antimicrobial resistance (2001) (42)
Neonatal Group B Streptococcal Disease: How Infection Control Teams Can Contribute to Prevention Efforts (2000) (42)
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics (2018) (42)
Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017. (2020) (41)
SARS Surveillance during Emergency Public Health Response, United States, March–July 2003 (2004) (41)
Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysis (2016) (40)
Two cases of invasive vancomycin-resistant group B streptococcus infection. (2014) (39)
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021 (2021) (38)
Applying Network Theory to Epidemics: Control Measures for Outbreaks of Mycoplasma pneumoniae (2001) (38)
TEMPERATURE DETERMINATION OF MALE OUTCROSSING ABILITY IN A SIMULTANEOUS HERMAPHRODITE (1992) (37)
Screening and Counseling Practices Reported by Obstetrician–Gynecologists for Patients With Hepatitis C Virus Infection (2003) (37)
A survey of emergency department 2009 pandemic influenza A (H1N1) surge preparedness--Atlanta, Georgia, July-October 2009. (2011) (36)
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data (2021) (35)
Prevention of neonatal sepsis. (2005) (34)
Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines (2021) (34)
Vital Signs: Health Care–Associated Legionnaires’ Disease Surveillance Data from 20 States and a Large Metropolitan Area — United States, 2015 (2017) (33)
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States (2021) (33)
Emerging and Reemerging Infectious Diseases: A Multidisciplinary Perspective (1998) (33)
The past and future of perinatal group B streptococcal disease prevention. (2004) (32)
Invasive Group B Streptococcal Disease in the Elderly, Minnesota, USA, 2003–2007 (2008) (31)
Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. (2011) (31)
Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001–2015 (2018) (31)
Temperature‐Determined Outcrossing Ability in Wild Populations of a Simultaneous Hermaphrodite Snail (1994) (31)
Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States (2018) (30)
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance. (2022) (30)
Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. (2012) (30)
Effects of Schistosoma haematobium infection on reproductive success and male outcrossing ability in the simultaneous hermaphrodite, Bulinus truncatus (Gastropoda: Planorbidae) (1994) (29)
Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa (2019) (28)
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States. (2017) (28)
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations (2019) (28)
Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa (2017) (28)
Addressing Needs of Contacts of Ebola Patients During an Investigation of an Ebola Cluster in the United States — Dallas, Texas, 2014 (2015) (27)
Sentinel Surveillance: A Reliable Way To Track Antibiotic Resistance in Communities? (2002) (27)
Vital Signs: Deficiencies in Environmental Control Identified in Outbreaks of Legionnaires’ Disease—North America, 2000–2014 (2016) (25)
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022 (2022) (25)
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron (2022) (25)
Emerging and reemerging infectious diseases: a multidisciplinary perspective. (1998) (24)
Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. (2000) (23)
Survey of American obstetricians regarding group B streptococcus: opinions and practice patterns. (2015) (22)
Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States (2015) (22)
Group B Streptococcus among Pregnant Women and Newborns in Mirzapur, Bangladesh: Colonization, Vertical Transmission, and Serotype Distribution (2017) (20)
Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions (2019) (19)
Heritability of male outcrossing ability in the simultaneous hermaphrodite, Bulinus truncatus (Gastropoda: Planorbidae) (1992) (19)
Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (2018) (19)
Group B streptococcal vaccine for resource-poor countries (2011) (19)
Loss of male outcrossing ability in simultaneous hermaphrodites: phylogenetic analyses of pulmonate snails (1996) (17)
Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. (2003) (15)
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology (2016) (15)
Chlorhexidine Maternal-Vaginal and Neonate Body Wipes in Sepsis and Vertical Transmission of Pathogenic Bacteria in South Africa: A Randomized, Controlled Trial (2010) (15)
Point Mutation in the Group B Streptococcal pbp 2 x Gene Conferring Decreased Susceptibility to Beta-Lactam Antibiotics Running title : First step pbp 2 x mutation in GBS (2008) (15)
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009. (2012) (15)
Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. (2004) (14)
The evolution of virulence: experimental evidence. (1991) (14)
Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. (2012) (14)
Legionnaires’ disease surveillance summary report, United States : 2014-1015 (2018) (14)
Aetiology of Neonatal Infection in South Asia (ANISA): An Initiative to Identify Appropriate Program Priorities to Save Newborns. (2016) (14)
Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. (2005) (12)
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States (2022) (11)
Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening-United States, 2016. (2019) (11)
Use of Real-Time PCR for Chlamydia psittaci Detection in Human Specimens During an Outbreak of Psittacosis — Georgia and Virginia, 2018 (2021) (10)
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021 (2021) (9)
Population-Based Assessment of Clinical Risk Factors for Legionnaires' Disease. (2020) (8)
Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study (2021) (7)
Evolution and ecological correlates of uniparental reproduction in freshwater snails (1995) (7)
Evolution and ecological correlates of uniparental and biparental reproduction in freshwater snails (1997) (7)
Intrapartum Antibiotic Exposure and Body Mass Index in Children. (2021) (7)
Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola (2018) (7)
Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia (2020) (6)
mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged >=16 Years in the United States, February to May 2021 (2021) (6)
Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (2018) (6)
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients (2022) (6)
Ecological Analysis of the Decline in Incidence Rates of COVID-19 Among Nursing Home Residents Associated with Vaccination, United States, December 2020-January 2021 (2021) (6)
Multistate analysis of prospective Legionnaires’ disease cluster detection using SaTScan, 2011–2015 (2019) (6)
Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998-2018. (2020) (6)
A human papillomavirus type 16 vaccine. (2003) (6)
Maternal colonisation with Streptococcus agalactiae, and associated stillbirth and neonatal disease in coastal Kenya. (2016) (5)
Development and Implementation of the ANISA Labeling and Tracking System for Biological Specimens (2016) (4)
Limiting the Spread of Resistant Pneumococci: Biological and Epidemiologic Evidence for the Effectiveness of Alternative Interventions (2000) (4)
Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility – Virginia, March-April 2021 (2022) (4)
UvA-DARE ( Digital Academic Repository ) Questions concerning the new haven coronavirus : letter (3)
Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) (2018) (3)
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study (2022) (3)
Intrapartum group B Streptococcal prophylaxis and childhood weight gain (2021) (3)
Infectious aetiologies of neonatal illness in south Asia classified using WHO definitions: a primary analysis of the ANISA study (2022) (2)
Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species — United States, January 2016–August 2022 (2022) (2)
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020. (2023) (2)
1337Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Non-Pregnant Adults (2014) (2)
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. (2022) (2)
Group B Streptococci: from Emerging Infection to Prevention Success Story (2000) (1)
Group B vaccine development : present status Streptococcus and future considerations , with emphasis on perspectives for low and middle income countries (2016) (1)
Trends in Group B Streptococcal Infections Among Infants <3 Months of Age and the Potential Impact of a Maternal Vaccine in the United States (2006-2014) (2016) (1)
Declines in perinatal group B streptococcal disease (2000) (0)
Reducing Infectious Diseases in Newborns: Promising Research on Low-Cost Sustainable Strategies (2004) (0)
85. Characterization of Group B streptococcus Strains with Reduced Susceptibility to Beta-lactam Antibiotics, Active Bacterial Core Surveillance, 1998–2017 (2020) (0)
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021 (2021) (0)
Are Children with Sickle Cell Disease (SCD) at Higher Risk of Developing Penicillin-Resistant Streptococcus pneumoniae (Pnc) Infections than Other Children? (1999) (0)
Group B streptococcal disease: unmet needs in high-income countries. (2019) (0)
Implementation of a Clinical Decision Support Tool to Improve Guideline Compliance in the Prevention of Early-Onset Group B Streptococcus Infections in Neonates (2015) (0)
Antibiotics -Lactam β Decreased Susceptibility to Gene Conferring pbp2x Streptococcal Mutation in the Group B (2014) (0)
Higher body mass index after intrapartum antibiotic exposure in children persists over 10-years. (2023) (0)
Risk Factors for Perinatal Escherichia coli Sepsis in the Era of Widespread Intrapartum Antibiotic Use (2006) (0)
Primaquine for all : is it time to simplify malaria treatment in co-endemic areas ? (2018) (0)
We write to you on behalf of the Informed Consent Action Network (“ICAN”) with regard to the non-peer reviewed paper titled Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity (2021) (0)
Maternal Immunization to Prevent Neonatal Group B Streptococcal Disease: New Progress and Promise. (2016) (0)
IN A SIMULTANEOUS HERMAPHRODITE (1992) (0)
Still Looking for a Simple, Effective Prevention Measure for Neonatal Sepsis in High-Mortality Settings. (2023) (0)
Early opportunities for prevention: infections of pregnant women and young infants. (2001) (0)
Risk factors for community-acquired bacterial infection among young infants in South Asia: a longitudinal cohort study with nested case–control analysis (2022) (0)
Enfermedad por estreptococos del grupo B en la era de la profilaxis antibiótica intraparto (2000) (0)
Group B Strep: Successful Model of "From Science to Action" (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephanie J. Schrag?

Stephanie J. Schrag is affiliated with the following schools:

Emory University
Indiana University
University of Oxford

Stephanie J. Schrag's Academic­Influence.com Rankings

Stephanie J. Schrag's Degrees

Why Is Stephanie J. Schrag Influential?

Stephanie J. Schrag's Published Works

Published Works

What Schools Are Affiliated With Stephanie J. Schrag?

Stephanie J. Schrag's AcademicInfluence.com Rankings